NCT05947526

Brief Summary

In this study, it is aimed to analyze the outcomes of embryos obtained from ovarian follicle with different sizes, and identify the microRNA expression in the spent media of the blastocysts cultures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

June 20, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 17, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2023

Completed
Last Updated

July 17, 2023

Status Verified

July 1, 2023

Enrollment Period

4 months

First QC Date

November 23, 2022

Last Update Submit

July 9, 2023

Conditions

Keywords

follicle sizemicro RNAblastocyst cultureembryo quality

Outcome Measures

Primary Outcomes (4)

  • Oocyte grading

    Morphologic Oocyte grading will be analyzed right after the procedure due to different follicle sizes

    after each hyper stimulation process of the patients, when the follicle sizes are large enough to pick up which is roughly 10-15 days after the hyper stimulation has started

  • Day-3 Embryo Grading

    Morphologic Day-3 embryo grading will be analyzed after the procedure due to different follicle sizes

    Three days after the intracytoplasminc sperm injection(ICSI) procedure

  • Day-5 Embryo Grading

    Day-5 embryo grading(Gardner classification) will be analyzed after the procedure due to different follicle sizes

    5 days after the intracytoplasminc sperm injection(ICSI) procedure

  • beta hCG results of the transferred embryos

    Clinical pregnancy outcomes

    ten days after the embryo transfer

Secondary Outcomes (1)

  • micro RNA expression in culture medium

    Culture mediums of day 5 embryos will be collected to be studied, after the last embryo is obtained and all will be studied at the end of the recruitment

Study Arms (1)

Women referring to infertility clinic for IVF treatment

Women who were referred to infertility clinic with complaint of not having baby go through IVF treatment, and having oocyte pick-up procedure with different sizes of ovarian follicles

Procedure: Oocyte pick-up

Interventions

With the needle, transvaginally USG-guided oocyte pick-up procedure is going to be performed

Women referring to infertility clinic for IVF treatment

Eligibility Criteria

Age20 Years - 38 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPatients must be all female, since the study is based on embryos obtained from different ovarian follicle sizes
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients who are going to be included to the study will be the patients of infertility clinic

You may qualify if:

  • Female patients aged between 20-38 who are planned to have IVF treatment
  • On the day of trigger before the oocyte pick-up, patients having at least 5, and 14 at most follicles exceeding 11mm
  • Patient having BMI below 30

You may not qualify if:

  • PCO patients
  • Patients having endometriosis
  • Patients having male factor with severe oligoazoospermia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acibadem University Atakent Hospital

Istanbul, 34303, Turkey (Türkiye)

RECRUITING

Related Publications (10)

  • Shapiro BS, Rasouli MA, Verma K, Raman A, Garner FC, Aguirre M, Kaye L, Bedient C. The effect of ovarian follicle size on oocyte and embryology outcomes. Fertil Steril. 2022 Jun;117(6):1170-1176. doi: 10.1016/j.fertnstert.2022.02.017. Epub 2022 Mar 30.

    PMID: 35367061BACKGROUND
  • Mohr-Sasson A, Orvieto R, Blumenfeld S, Axelrod M, Mor-Hadar D, Grin L, Aizer A, Haas J. The association between follicle size and oocyte development as a function of final follicular maturation triggering. Reprod Biomed Online. 2020 Jun;40(6):887-893. doi: 10.1016/j.rbmo.2020.02.005. Epub 2020 Feb 20.

    PMID: 32389425BACKGROUND
  • Costermans NGJ, Soede NM, van Tricht F, Blokland M, Kemp B, Keijer J, Teerds KJ. Follicular fluid steroid profile in sows: relationship to follicle size and oocyte qualitydagger. Biol Reprod. 2020 Mar 13;102(3):740-749. doi: 10.1093/biolre/ioz217.

    PMID: 31786607BACKGROUND
  • Rosen MP, Shen S, Dobson AT, Rinaudo PF, McCulloch CE, Cedars MI. A quantitative assessment of follicle size on oocyte developmental competence. Fertil Steril. 2008 Sep;90(3):684-90. doi: 10.1016/j.fertnstert.2007.02.011. Epub 2008 Feb 4.

    PMID: 18249377BACKGROUND
  • Annes K, Muller DB, Vilela JAP, Valente RS, Caetano DP, Cibin FWS, Milazzotto MP, Mesquita FS, Belaz KRA, Eberlin MN, Sudano MJ. Influence of follicle size on bovine oocyte lipid composition, follicular metabolic and stress markers, embryo development and blastocyst lipid content. Reprod Fertil Dev. 2019 Mar;31(3):462-472. doi: 10.1071/RD18109.

    PMID: 30282571BACKGROUND
  • Orvieto R, Mohr-Sasson A, Blumenfeld S, Nahum R, Aizer A, Haas J. Does a Large (>24 mm) Follicle Yield a Competent Oocyte/Embryo? Gynecol Obstet Invest. 2020;85(5):416-419. doi: 10.1159/000510876. Epub 2020 Sep 23.

    PMID: 32966987BACKGROUND
  • Kasapoglu I, Orhan A, Aslan K, Sen E, Kaya A, Avci B, Uncu G. Are all antral follicles the same? Size of antral follicles as a key predictor for response to controlled ovarian stimulation. J Obstet Gynaecol. 2022 Apr;42(3):461-466. doi: 10.1080/01443615.2021.1910640. Epub 2021 Jun 22.

    PMID: 34155958BACKGROUND
  • Saith RR, Srinivasan A, Michie D, Sargent IL. Relationships between the developmental potential of human in-vitro fertilization embryos and features describing the embryo, oocyte and follicle. Hum Reprod Update. 1998 Mar-Apr;4(2):121-34. doi: 10.1093/humupd/4.2.121.

    PMID: 9683350BACKGROUND
  • Wittmaack FM, Kreger DO, Blasco L, Tureck RW, Mastroianni L Jr, Lessey BA. Effect of follicular size on oocyte retrieval, fertilization, cleavage, and embryo quality in in vitro fertilization cycles: a 6-year data collection. Fertil Steril. 1994 Dec;62(6):1205-10. doi: 10.1016/s0015-0282(16)57186-6.

    PMID: 7957985BACKGROUND
  • Orvieto R, Mohr-Sasson A, Aizer A, Nahum R, Blumenfeld S, Kirshenbaum M, Haas J. Do Follicles of Obese Patients Yield Competent Oocytes/Embryos? Gynecol Obstet Invest. 2020;85(3):290-294. doi: 10.1159/000508226. Epub 2020 Jun 2.

    PMID: 32485714BACKGROUND

Study Officials

  • NAZLI ALBAYRAK, MD

    Acıbadem University School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident, MD

Study Record Dates

First Submitted

November 23, 2022

First Posted

July 17, 2023

Study Start

June 20, 2023

Primary Completion

October 20, 2023

Study Completion

December 10, 2023

Last Updated

July 17, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

IPD is not going to be shared with other researchers. All data is going to be known only by one researcher.

Locations